Anticoagulation therapy: Sulodexide reduces the risk of recurrent venous thromboembolism
- PMID: 26461966
- DOI: 10.1038/nrcardio.2015.163
Anticoagulation therapy: Sulodexide reduces the risk of recurrent venous thromboembolism
Comment on
-
Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.Circulation. 2015 Nov 17;132(20):1891-7. doi: 10.1161/CIRCULATIONAHA.115.016930. Epub 2015 Sep 25. Circulation. 2015. PMID: 26408273 Free PMC article. Clinical Trial.
References
-
- Circulation. 2015 Nov 17;132(20):1891-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical